Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Shares Shorted: Short Interest Down 98.4% in October

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the target of a significant drop in short interest in October. As of October 15th, there was short interest totaling 647 shares, a drop of 98.4% from the September 30th total of 39,624 shares. Based on an average daily volume of 102,484 shares, the short-interest ratio is presently 0.0 days.

Ono Pharmaceutical Stock Down 0.5%

OPHLY stock traded down $0.02 during midday trading on Monday, hitting $5.25. The company’s stock had a trading volume of 42,501 shares, compared to its average volume of 37,629. The company’s fifty day moving average price is $5.04 and its 200 day moving average price is $5.01. Ono Pharmaceutical has a twelve month low of $3.82 and a twelve month high of $5.75.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd. is a Japan-based, research-driven pharmaceutical company that discovers, develops, manufactures and markets prescription medicines. Its activities focus primarily on areas of high unmet medical need, including oncology, immunology, neurology and other specialty-care fields.

The company’s best-known product is Opdivo (nivolumab), an immune checkpoint inhibitor used in the treatment of multiple cancers. Ono has also developed or commercialized other specialty medicines, including treatments for cancer and immune-related conditions, through internal research and collaborations with pharmaceutical companies in Japan and overseas.

Ono Pharmaceutical traces its origins to 1717, when it began as a drug wholesaler in Osaka, and was incorporated in its modern corporate form in 1947.